| 000 | 01676 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250516015453.0 | ||
| 264 | 0 | _c20110310 | |
| 008 | 201103s 0 0 eng d | ||
| 022 | _a1527-7755 | ||
| 024 | 7 |
_a10.1200/JCO.2010.33.0332 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKusumoto, Shigeru | |
| 245 | 0 | 0 |
_aClinical significance of hepatitis B virus (HBV)-DNA monitoring to detect HBV reactivation after systemic chemotherapy. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cFeb 2011 |
||
| 300 |
_ae100; author reply e101 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aDNA, Viral _xblood |
| 650 | 0 | 4 | _aEarly Diagnosis |
| 650 | 0 | 4 |
_aHepatitis B _xdiagnosis |
| 650 | 0 | 4 |
_aHepatitis B Antibodies _xblood |
| 650 | 0 | 4 |
_aHepatitis B virus _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xdrug therapy |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aVirus Activation |
| 700 | 1 | _aTanaka, Yasuhito | |
| 700 | 1 | _aMizokami, Masashi | |
| 700 | 1 | _aUeda, Ryuzo | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 29 _gno. 4 _gp. e100; author reply e101 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2010.33.0332 _zAvailable from publisher's website |
| 999 |
_c20461172 _d20461172 |
||